Skip to main content
Article
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
New England Journal of Medicine
  • Sophia Zoungas, University of Sydney
  • John Chalmers, University of Sydney
  • Bruce Neal, University of Sydney
  • Laurent Billot, George Institute for Global Health
  • Qiang Li, George Institute for Global Health
  • Yoichiro Hirakawa, George Institute for Global Health
  • Hisatomi Arima, George Institute for Global Health
  • Helen Monaghan, George Institute for Global Health
  • Rohini Joshi, George Institute for Global Health
  • Stephen Colagiuri, Boden Institute
  • Mark Cooper, Baker IDI Heart and Diabetes Institute
  • Paul Glasziou, Bond University
  • Diederick E. Grobbee, Utrecht University
  • Pavel Hamet, University of Montreal
  • Stephen Harrap, University of Melbourne
  • Simon Heller, Sheffield Teaching Hospital
  • Liu Lisheng, Chinese Hypertension League Institute
  • Giuseppe Mancia, University of Milano-Bicocca
  • Michel Marre, Hôpital Bichat–Claude Bernard
  • David Matthews, University of Oxford
  • Carl-Erik Mogensen, Aarhus University
  • Vlado Perkovic, University of Sydney
  • Neil Poulter, Imperial College London
  • Anthony Rodgers, The University of Auckland
  • Brian Williams, University of Leicester
  • Stephen MacMahon, University of Sydney
  • Anushka Patel, University of Sydney
  • Mark Woodward, University of Sydney
Date of this Version
10-9-2015
Document Type
Journal Article
Publication Details

Citation only

Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., Cooper, M., Glasziou, P., Grobbee, D., Hamet, P., Harrap, S., Heller, S., Lisheng, L., Mancia, G., Marre, M., Matthews, D., Mogensen, C., Perkovic, V., Poulter, N., Rodgers, A., Williams, B., MacMahon, S., Patel, A., & Woodward, M. (2014). Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New England Journal of Medicine, 371(15), 1392-1406.

Access the journal

© Copyright, Massachusetts Medical Society, 2014

2014 HERDC Submission

NHMRC Project Grant

Abstract

The benefits with respect to mortality that had been observed among patients originally assigned to blood-pressure–lowering therapy were attenuated but still evident at the end of follow-up. There was no evidence that intensive glucose control during the trial led to long-term benefits with respect to mortality or macrovascular events.

Citation Information
Sophia Zoungas, John Chalmers, Bruce Neal, Laurent Billot, et al.. "Follow-up of blood-pressure lowering and glucose control in type 2 diabetes" New England Journal of Medicine (2015) ISSN: 0028-4793
Available at: http://works.bepress.com/paul_glasziou/158/